BMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMS 599626 is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50=22, 32 and 190 nM, respectively) with potential antineoplastic activity.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PageBMY 7378 is a 5-HT1A partial agonist and high affinity ??1D adrenoceptor antagonist.
More Information Supplier PagePNU-120596 is a positive allosteric modulator of ??7 neuronal nicotinic acetylcholine receptors.
More Information Supplier PagePNU-120596 is a positive allosteric modulator of ??7 neuronal nicotinic acetylcholine receptors.
More Information Supplier PageThe S-enantiomer of A66 is a potent inhibitor of the p110alpha isoform of PI 3-kinase (PIK3CA).
More Information Supplier Page
